FDA DEVICE FACTS
MiniMed 780G System
Medtronic Minimed, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The MiniMed 780G system is indicated for use with either the Simplera Sync Sensor, or with the Guardian 4 sensor/Guardian 4 transmitter. Indications for use for the MiniMed 780G system are provided for each of the two system configurations separately:
MiniMed 780G System with Simplera Sync Sensor: The MiniMed 780G system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons 7 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The MiniMed 780G system consists of the following devices:
• MiniMed 780G insulin pump
• Simplera Sync
• Accu-Chek™ Guide Link blood glucose meter
• Accu-Chek Guide Test Strips
The system requires a prescription from a healthcare professional.
Simplera Sync Sensor The Simplera Sync sensor is intended for use with the MiniMed 780G system to monitor glucose levels for the management of diabetes. The Simplera Sync sensor can be used one time and has a life of up to 6 days, followed by a grace period of 24 hours. During the grace period, the sensor will continue to work as it did during the first 6 days, to allow the patient to change their sensor more flexibly. However, some sensors may not survive the full wear period for a variety of reasons. Please be prepared to replace the sensor during the grace period to ensure sensor glucose values continue to be monitored.
The Simplera Sync sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in Manual mode. All therapy adjustments in Manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Simplera Sync sensor. The Simplera Sync sensor has been studied and is approved for use in the systems, insertion sites, and ages listed in the following table.
System Approved Age Sensor Insertion Site MiniMed 780G system 7 years and older Arm Accu-Chek Guide Link Blood Glucose Monitoring System The Accu-Chek Guide Link Blood Glucose Monitoring System is comprised of the Accu- Chek Guide Link meter and the Accu-Chek Guide test strips. The Accu-Chek Guide Link Blood Glucose Monitoring System is intended to quantitatively measure glucose in fresh capillary whole blood from the fingertip, palm, and upper arm as an aid in monitoring the effectiveness of glucose control.
The Accu-Chek Guide Link Blood Glucose Monitoring System is intended for in vitro diagnostic single-patient use by people with diabetes. The Accu-Chek Guide Link Blood Glucose Monitoring System is intended to be used by a single person and should not be shared.
This system is not for use in diagnosing or screening for diabetes mellitus and not for neonatal use. Alternative site testing should be done only during steady-state times (when glucose is not changing rapidly). The Accu-Chek Guide Link Blood Glucose Monitoring System is intended to be used to wirelessly transmit glucose values to the MiniMed 780G system and MiniMed 770G system with Bluetooth™ wireless technology through the use of Bluetooth low energy communication.
MiniMed 780G System with Guardian 4 Sensor and Guardian 4 Transmitter: The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons 7 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.
The MiniMed 780G system consists of the following devices:
• MiniMed 780G insulin pump
• Guardian 4 transmitter
• Guardian 4 sensor
• One-press serter
• Accu-Chek Guide Link blood glucose meter
• Accu-Chek Guide Test Strips
The system requires a prescription from a healthcare professional.
Guardian 4 sensor The Guardian 4 sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian 4 sensor is indicated for up to 7 days of continuous use. The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor.
The Guardian 4 sensor has been studied and is approved for use in the systems, insertion sites, and ages listed in the following table.
System Age Sensor Insertion Site MiniMed 780G system 7 years and older Arm
One-press Serter The serter is used as an aid for inserting the sensor. It is indicated for single-patient use and it is not intended for multiple-patient use.
Guardian 4 transmitter The Guardian 4 transmitter is intended for use with the MiniMed 780G system and Guardian 4 sensor to monitor glucose levels for the management of diabetes.
Accu-Chek Guide™ Link Blood Glucose Monitoring System The Accu-Chek Guide Link Blood Glucose Monitoring system is comprised of the Accu- Chek Guide Link meter and the Accu-Chek Guide test strips. The Accu-Chek Guide Link Blood Glucose Monitoring System is intended to quantitatively measure glucose in fresh capillary whole blood from the fingertip, palm, and upper arm as an aid in monitoring the effectiveness of glucose control. The Accu-Chek Guide Link Blood Glucose Monitoring System is intended for in-vitro diagnostic single-patient use by people with diabetes. The Accu-Chek Guide Link Blood Glucose Monitoring System is intended to be used by a single person and should not be shared. This system is not for use in diagnosing or screening for diabetes mellitus and not for neonatal use. Alternative site testing should be done only during steady-state times (when glucose is not changing rapidly). The Accu- Chek Guide Link Blood Glucose Monitoring System is intended to be used to wirelessly transmit glucose values to the MiniMed 780G system and MiniMed 770G system with Bluetooth wireless technology through the use of Bluetooth low energy communication.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。